Genolution Documenten
Documenten
0
Ticker
225220.KQ
ISIN
KR7225220003
Genolution SEC Filings
Type | Bericht | Datum |
|---|---|---|
| Geen documenten beschikbaar | ||
Genolution Documenten 2026
Deze pagina bevat alle officiële documenten en SEC-filings voor Genolution aandelen (225220.KQ, ISIN: KR7225220003). Dit omvat jaarverslagen (Formulier 10-K), kwartaalrapporten (Formulier 10-Q) en insidertransacties (Formulier 4). Momenteel zijn 0 documenten beschikbaar. Gegevens worden regelmatig bijgewerkt om beleggers een volledig overzicht van Genolution's regelgevingsfilings te bieden.
Genolution Aandelenanalyse
Genolution Genolution Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company has 87 employees and completed its initial public offering (IPO) on August 3, 2015. Genolution focuses on the research and development of nucleic acid extractors, offering products such as automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also provides ribonucleic acid interference services. Genolution distributes its products both domestically within South Korea and internationally to overseas markets. The company's website is https://genolution.co.kr/.